A Neonate Diagnosed with Megalencephaly-Capillary Malformation-Polymicrogyria Syndrome with PIK3CA Mutation
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Megalencephaly-capillary malformation-polymicrogyria syndrome (MCAP) is a rare genetic disorder characterized by megalencephaly, polymicrogyria, body overgrowth, and cutaneous capillary malformations. It has been reported recently that MCAP is related to a somatic mosaic mutation in the phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) gene. We report a case of hemimegalencephaly with polymicrogyria and cutaneous capillary malformations diagnosed by genetic evaluation of MCAP in the neonatal period. The PIK3CA mutation [c.1635G>T (p. Glu545Asp)] was determined by Sanger sequencing. The patient was treated with a ventriculoperitoneal shunt for progressive hydrocephalus. Because of the dynamic, progressive clinical manifestations and tumor-prone traits of MCAP, early diagnosis is important. Moreover, since the phosphoinositide 3-kinase (PI3K)-specific inhibitor, a targeted therapy for the PI3K/AKT/mTOR signaling pathway is emerging as a new therapy, early genetic diagnosis is becoming increasingly important.
Abstract
Megalencephaly-capillary malformation-polymicrogyria syndrome (MCAP) is a rare genetic disorder characterized by megalencephaly, polymicrogyria, body overgrowth, and cutaneous capillary malformations. It has been reported recently that MCAP is related to a somatic mosaic mutation in the phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) gene. We report a case of hemimegalencephaly with polymicrogyria and cutaneous capillary malformations diagnosed by genetic evaluation of MCAP in the neonatal period. The PIK3CA mutation [c.1635G>T (p. Glu545Asp)] was determined by Sanger sequencing. The patient was treated with a ventriculoperitoneal shunt for progressive hydrocephalus. Because of the dynamic, progressive clinical manifestations and tumor-prone traits of MCAP, early diagnosis is important. Moreover, since the phosphoinositide 3-kinase (PI3K)-specific inhibitor, a targeted therapy for the PI3K/AKT/mTOR signaling pathway is emerging as a new therapy, early genetic diagnosis is becoming increasingly important.
참고문헌 (17)
- Mirzaa GM, "Megalencephaly-capillary malformation (MCAP) and megalencephaly-polydactyly-polymicrogyria-hydrocephalus (MPPH) syndromes: two closely related disorders of brain overgrowth and abnormal brain and body morphogenesis", Am J Med Genet A, 158A, pp.269~291 (2012)
- Wright DR, "The misnomer “macrocephaly-cutis marmorata telangiectatica congenita syndrome”: report of 12 new cases and support for revising the name to macrocephaly-capillary malformations", Arch Dermatol, 145, pp.287~293 (2009)
- Martinez-Glez V, "Macrocephaly-capillary malformation:analysis of 13 patients and review of the diagnostic criteria", Am J Med Genet A, 152A, pp.3101~3106 (2010)
- Mirzaa GM, "Megalencephaly syndromes and activating mutations in the PI3K-AKT pathway: MPPH and MCAP", Am J Med Genet C Semin Med Genet, 163C, pp.122~130 (2013)
- Akgumus G, "Overgrowth syndromes caused by somatic variants in the phosphatidylinositol 3-kinase", AKT, J Mol Diagn, pp.2017, 19[DOI]
- Keppler-Noreuil KM, "Somatic overgrowth disorders of the PI3K", AKT, Am J Med Genet C Semin Med Genet, pp.2016, 172[DOI]
- Gripp KW, "Nephroblastomatosis or Wilms tumor in a fourth patient with a somatic PIK3CA mutation", Am J Med Genet A, 170, pp.2559~2569 (2016)
- Venot Q, "Targeted therapy in patients with PIK3CA-related overgrowth syndrome", Nature, 558, pp.540~546 (2018)
- Yeon Chul Choi, "Megalencephaly-capillary malformation-poly- microgyria syndrome: the first case report in Korea", Clinical and Experimental Pediatrics, 59, pp.152~156 (2016), 대한소아청소년과학회
- 박성민, "Megalencephaly-capillary Malformation Syndrome", 대한피부과학회지, 53(7), pp.546~551 (2015), 대한피부과학회
- Kim YM, "Clinical and genetic analyses of patients with lateralized overgrowth", BMC Med Genomics, 15, pp.206~ (2022)
- Park HJ, "Detailed analysis of phenotypes and genotypes in megalencephaly-capillary malformation-polymicrogyria syndrome caused by somatic mosaicism of PIK3CA mutations", Orphanet J Rare Dis, 15, pp.205~ (2020)
- Clayton-Smith J, "Macrocephaly with cutis marmorata, haemangioma and syndactyly: a distinctive overgrowth syndrome", Clin Dysmorphol, 6, pp.291~302 (1997)
- Fortin O, "Megalencephaly-capillary malformation-polymicrogyria with cerebral venous thrombosis", Can J Neurol Sci, 47, pp.828~829 (2020)
- Di Rocco F, "Surgical management of Chiari malformation type 1 associated to MCAP syndrome and study of cerebellar and adjacent tissues for PIK3CA mosaicism", Eur J Med Genet, 66, pp.104678~ (2023)
- Madsen RR, "Cancer-associated PIK3CA mutations in overgrowth disorders", Trends Mol Med, 24, pp.856~870 (2018)
- Morin G, "Treatment of two infants with PIK3CA-related overgrowth spectrum by alpelisib", J Exp Med, 219, pp.e20212148~ (2022)